Gene · 57823
SLAMF7: SLAM family member 7
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SLAMF7: SLAM family member 7. Genes, record 57823. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57823
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9NQ25 | SLAM family member 7 | 335 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents425
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4713439 A1 | 2026-03-25 | 248 | Q9NQ25 | Espacenet |
| JP 2026035661 A | 2026-03-04 | 966 | Q9NQ25 | Espacenet |
| EP 4676978 A1 | 2026-01-14 | 23 | Q9NQ25 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 63686 | Q9NQ25 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8354 | Q9NQ25 | Espacenet |
| JP 2025164866 A | 2025-10-30 | 8 | Q9NQ25 | Espacenet |
| EP 4626924 A1 | 2025-10-08 | 1 | Q9NQ25 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 12320 | Q9NQ25 | Espacenet |
| US 12421291 B2 | 2025-09-23 | 966 | Q9NQ25 | Espacenet |
| WO 2025191133 A1 | 2025-09-18 | 56 | Q9NQ25 | Espacenet |
1 to 10 of 425
See all 425 patentsDrugs2
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials65
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT06785415 | ELOTUZUMAB | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT06518551 | ELOTUZUMAB | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT06208150 | ELOTUZUMAB | PHASE3 | ClinicalTrials.gov | |
| NCT06163040 | ELOTUZUMAB | ClinicalTrials.gov | ||
| NCT06158841 | ELOTUZUMAB | PHASE3 | ClinicalTrials.gov | |
| NCT05981209 | ELOTUZUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT05730036 | ELOTUZUMAB | PHASE3 | ClinicalTrials.gov | |
| NCT05675319 | ELOTUZUMAB | PHASE3 | ClinicalTrials.gov | |
| NCT05560399 | ELOTUZUMAB | EARLY_PHASE1 | ClinicalTrials.gov | |
| NCT05170789 | ELOTUZUMAB | PHASE2 | ClinicalTrials.gov |
1 to 10 of 65
See all 65 trialsNIH grants1,610
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SLAMF7 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 33 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 25 | 2025 |
| P01CA155258 | Integrative Oncogenomics of Multiple Myeloma | 20 | 2025 |
| U19AI110495 | An autoimmune center of excellence for the study of IgG4-related disease | 12 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 10 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 9 | 2025 |
| P50CA186781 | Mayo Clinic Multiple Myeloma SPORE | 9 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 7 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 7 | 2025 |
| P01CA065493 | Off-the-Shelf Immune Effector Cells for Hematological Malignancies | 6 | 2025 |
1 to 10 of 1,610Source NIH's project files
See all 1,610 nih grantsPapers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impaired antigen clearance of macrophages associates with heart failure and non-obstructive azoospermia: insights from transcriptomics, in silico knockout, and in vitro validation. | Front Immunol | 2026 | 42812170 | PubTator, text mining | PubMed |
| GPR56 and CD319 identify distinct cytotoxic-associated DP and DN T-cell subsets in early systemic lupus erythematosus. | Clin Rheumatol | 2026 | 42745124 | PubTator, text mining | PubMed |
| Proteomics in the discovery of biomarkers of major complications after allogeneic hematopoietic cell transplantation. | Curr Opin Hematol | 2026 | 42673525 | PubTator, text mining | PubMed |
| Abatacept Reduces CD319+ (SLAMF7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis. | Arthritis Rheumatol | 2026 | 42621795 | PubTator, text mining | PubMed |
| CXCR6 and its correlated G protein-coupled receptors and PI3K-AKT pathways were associated with the progression of thyroid cancer. | BMC Cancer | 2026 | 42432576 | PubTator, text mining | PubMed |
| Expression of SLAMF7 on hairy cell leukemia indicates therapy option with SLAMF7-antibody Elotuzumab. | Leuk Res Rep | 2026 | 42367242 | PubTator, text mining | PubMed |
| Harnessing CAR-NK cells against multiple myeloma: current landscape and future directions. | Mol Biol Rep | 2026 | 42240912 | PubTator, text mining | PubMed |
| RNA binding protein YWHAZ mediates specific mRNA translation and regulates cell proliferation and apoptosis in diabetic foot ulcer. | Front Med (Lausanne) | 2026 | 42180716 | PubTator, text mining | PubMed |
| Elotuzumab enhances the anti-tumor activity of Vγ9Vδ2 T cells against primary effusion lymphoma. | Eur J Pharmacol | 2026 | 42081990 | PubTator, text mining | PubMed |
| Large Vessel Vasculitis: Recent Advances in Pathophysiology and Targeted Therapies. | Drugs | 2026 | 42081084 | PubTator, text mining | PubMed |
1 to 10 of 3,217
See all 3,217 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57823
GET https://conductscience.org/api/genes/v1/57823/patents?page=2